Diagnosing and treating breast cancer in elderly women: A call for improved understanding

Journal of the American Geriatrics Society

Volumn 55, Issue 10, 2007, Pages 1636-1644

  Downey, Leona ^a,b   Livingston, Robert ^a   Stopeck, Alison ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b NONE   (United States)

Author keywords

Breast; Cancer; Diagnosis; Elderly; Treatment

Indexed keywords

ANASTROZOLE; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; CAPECITABINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EXEMESTANE; FLUOROURACIL; FULVESTRANT; GEMCITABINE; HEMOPOIETIC GROWTH FACTOR; LAPATINIB; LETROZOLE; METHOTREXATE; METRONOMIC; NAVELBINE; PACLITAXEL; PROTEIN TYROSINE KINASE INHIBITOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SUNITINIB; TAMOXIFEN; TRASTUZUMAB; UNCLASSIFIED DRUG; WARFARIN;

ARTHRALGIA; ARTICLE; BLEEDING; BONE DENSITY; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; FEBRILE NEUTROPENIA; FRACTURE; HORMONAL THERAPY; HOT FLUSH; HUMAN; INCIDENCE; MASTECTOMY; METASTASIS; MULTIPLE CYCLE TREATMENT; PARTIAL MASTECTOMY; PATHOLOGY; PATIENT CARE; PATIENT COUNSELING; RISK ASSESSMENT; SIDE EFFECT; STROKE; VENOUS THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; PROGNOSIS; SEER PROGRAM; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 34848816556     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2007.01369.x     Document Type: Article

References (49)

1. Surveillance Epidemiology and End Results (SEER) Cancer Statistics Review 1975-2002, based on SEER data submission 2004 [on-line]. Available at Accessed March, 15, 2006.
2. Yancik R. Cancer burden in the aged: An epidemiologic and demographic overview. Cancer 1997 80 : 1273 1283.
3. Eppenberger-Castori S, Moore DH Jr., Thor AD et al. Age associated biomarker profiles of human breast cancer. Int J Biochem Cell Biol 2002 34 : 1318 1330.
4. Diab SG, Elledge RM, Clark GM et al. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 2000 92 : 550 556.
5. McCarthy EP, Burns RB, Freund KM et al. Mammography use, breast cancer stage at diagnosis and survival among older women. J Am Geriatr Soc 2000 48 : 1226 1233.
6. Litvak DA, Arora R. Treatment of elderly breast cancer patients in a community hospital setting. Arch Surg 2006 141 : 989 990.
7. McPherson CP, Swenson KK, Lee MW. The effects of mammographic detection and comorbidity on the survival of older women with breast cancer. J Am Geriatr Soc 2002 50 : 1061 1068.
8. Wanebo HJ, Cole B, Chung M et al. Is surgical management compromised in elderly patients with breast cancer? Ann Surg 1997 225 : 579 589.
9. August DA, Rea T, Sondak VK et al. Age related differences in breast cancer treatment. Ann Surg Oncol 1994 1 : 45 52.
10. Kessler HJ, Seton JZ. The treatment of operable breast cancer in the elderly female. Am J Surg 1978 135 : 664 666.
11. Bouchardy C, Rapiti E, Fioretta G et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 2003 21 : 3580 3587.
12. Fentiman IS, Christiaens MR, Paridaens R et al. Treatment of operable breast cancer in the elderly: A randomized clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy. Eur J Cancer 2003 39 : 309 316.
13. Mustacchi G, Ceccherini R, Milani S et al. Tamoxifen alone vs adjuvant tamoxifen for operable breast cancer: Long term results of the phase III randomized controlled multicenter GRETA trial. Ann Oncol 2003 14 : 414 420.
14. Bates T, Riley DL, Houghton J et al. Breast cancer in elderly women: A Cancer Research Campaign Trial comparing tamoxifen and optimal surgery with tamoxifen alone. Br J Surg 1991 78 : 591 594.
15. Samain E, Schauvliege F, Deval B et al. Anesthesia for breast cancer surgery in the elderly. Crit Rev Oncol Hematol 2003 46 : 115 120.
16. Hughes K, Schnaper LA, Berry D et al. Lumpectomy plus tamoxifen with or without radiation in women 70 years of age or older with early breast cancer: A report of further follow-up. Breast Cancer Res Treat 2006 100 (Suppl 1) : 8.
17. Witherby SM, Muss HB. Update in medical oncology for older patients: Focus on breast cancer: Management of early breast cancer. Cancer J 2005 11 : 506 517.
18. Extermann M, Balducci L, Muss H. What threshold for adjuvant therapy in older breast cancer patients? J Clin Oncol 2000 18 : 1709 1717.
19. Carey EC, Walter LC, Lindquist K et al. Development and validation of a functional morbidity index to predict mortality in community dwelling elders. J Gen Intern Med 2004 19 : 1027 1033.
20. Saliba D, Elliott M, Rubenstein LZ et al. The Vulnerable Elders Survey: A tool for identifying vulnerable older people in the community. J Am Geriatr Soc 2001 49 : 1691 1699.
21. Wolinsky FD, Miller DK, Andersen DM et al. Effect of subclinical status in functional limitation and disability on adverse outcomes 3 years later. J Gerontol A Biol Sci Med Sci 2007 62A : M101 M106.
22. Hurria A, Landis MS, Cohen HJ et al. Geriatric assessment for oncologists: Rationale and future directions. Crit Rev Oncol Hematol 2006 59 : 211 217.
23. Paik S, Shak S, Tang K et al. A multigene assay to predict recurrence of tamoxifen-treated node negative breast cancer. N Engl J Med 2004 351 : 2817 2826.
24. Paik S, Tang G, Shak S et al. Gene expression and benefit of chemotherapy in node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 2006 24 : 3726 3734.
25. The ATAC Trialists Group. Comprehensive side effect profile of anastrazole and tamoxifen as adjuvant treatment for early stage breast cancer: Long term safety analysis of the ATAC trial. Lancet Oncol 2006 7 : 633 643.
26. Thurlimann B, Keshaviah A, Coates AS et al. The Breast International Group (BIG) 1-98 Collaborative Group. A comparison of letrozole and tamoxifen in post menopausal women with early breast cancer. N Engl J Med 2005 353 : 2747 2757.
27. Howell A, Cuzick J, Baum M et al. Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial after 5 years of adjuvant therapy for breast cancer. Lancet 2005 365 : 60 62.
28. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education (NCEP) Expert Panel on Detection, Education, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 285 : 2486 2497.
29. Ramaswamy B, Shapiro CL. Osteopenia and osteoporosis in women with breast cancer. Semin Oncol 2003 30 : 763 775.
30. Early Breast Cancer Trialist's Group. Tamoxifen for early breast cancer: An overview of the randomized trials. Lancet 1998 351 : 1451 1467.
31. Coombes RC, Hall E, Gibson LJ et al. A randomized trial of exemestane after 2 to 3 years of tamoxifen in post menopausal women with primary breast cancer. N Engl J Med 2004 350 : 1081 1092.
32. Goss PE, Ingle JN, Martino S et al. A randomized trial of letrozole after 5 years of tamoxifen in post menopausal women with early-stage breast cancer. N Engl J Med 2003 349 : 1793 1802.
33. Goss PE, Ingle JN, Martino S et al. Updated analysis of NCIC CTG MA.17 randomized placebo controlled trial of letrozole after 5 years of tamoxifen in post menopausal women with early stage breast cancer [abstract 847]. Proc Am Soc Clin Oncol 2004 23 : 87.
34. Gomez H, Mas L, Casanova L et al. Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte- macrophage-colony stimulating factor: Identification of two age subgroups with differing hematologic toxicity. J Clin Oncol 1998 16 : 2352 2358.
35. Zinzani PL, Pavone E, Storti S et al. Randomized trial with or without granulocyte-colony stimulating factor as adjunct to induction VNCOP-B for elderly high grade non-Hodgkin's lymphoma. Blood 1997 89 : 3974 3979.
36. Hurria A, Brogan K, Panageas KS et al. Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy. Breast Cancer Res Treat 2005 92 : 151 156.
37. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology V 1 2005, and V 1 2006 [on-line]. Available at Accessed June 15, 2006.
38. Lyman GH, Kuderer N, Agboola O et al. Evidence based use of colony stimulating factors in elderly cancer patients. Cancer Control 2003 10 : 487 499.
39. Mouridsen H, Sun Y, Gershanovich M et al. Superiority of letrozole to tamoxifen in the first line treatment of advanced breast cancer: Evidence from metastatic subgroups and a test of functional ability. Oncologist 2004 9 : 489 496.
40. Ingle JN, Suman VJ, Rowland KM et al. Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032. J Clin Oncol 2006 24 : 1052 1056.
41. Liu G, Franssen E, Fitch MI et al. Patient preference for oral versus intravenous palliative chemotherapy. J Clin Oncol 1997 15 : 110 115.
42. Ershler WB. Capecitabine monotherapy: Safe and effective treatment for metastatic breast cancer. Oncologist 2006 11 : 325 335.
43. Orlando L, Cardillo A, Rocca A et al. Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer. Anticancer Drugs 2006 17 : 961 967.
44. Miller KD. A randomized phase III trial of paclitaxel vs paclitaxel plus bevacizumab as first line therapy in locally recurrent or metastatic breast cancer: A trial organized by the Eastern Cooperative Oncology Group (E2100) [abstract 3]. 2005. San Antonio Breast Cancer Symposium, San Antonio, TX.
45. Kerlikowske K, Grady D, Rubin SM et al. Efficacy of screening mammography. A meta-analysis. JAMA 1995 273 : 149 154.
46. Balducci L. Prevention of cancer in the older person. Cancer J 2005 11 : 442 448.
47. McCarthy EP, Burns RB, Ferund KM et al. Mammography use, breast cancer stage at diagnosis and survival among older women. J Am Geriatr Soc 2000 48 : 1226 1233.
48. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002 288 : 321 323.
49. Morimoto LM, White E, Chen Z et al. Obesity, body size, and risk of post-menopausal breast cancer: The Women's Health Initiative. Cancer Causes Control 2002 13 : 741 751.